AGGRESSIVE NK CELL LEUKEMIA

Clinical trials for AGGRESSIVE NK CELL LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new AGGRESSIVE NK CELL LEUKEMIA trials appear

Sign up with your email to follow new studies for AGGRESSIVE NK CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug tested for Tough-to-Treat blood cancers

Disease control Recruiting now

This is the first study in people to test an experimental drug called DR-01 for adults with rare and aggressive blood cancers, including large granular lymphocytic leukemia (LGLL) and several types of cytotoxic lymphomas. The main goals are to find a safe dose and see if the drug…

Matched conditions: AGGRESSIVE NK CELL LEUKEMIA

Phase: PHASE1, PHASE2 • Sponsor: Dren Bio • Aim: Disease control

Last updated Mar 11, 2026 14:54 UTC

AGGRESSIVE NK CELL LEUKEMIA

Get alerted when new AGGRESSIVE NK CELL LEUKEMIA trials appear

New drug tested for Tough-to-Treat blood cancers